» Articles » PMID: 28040478

Cathepsin K Cleavage of SDF-1α Inhibits Its Chemotactic Activity Towards Glioblastoma Stem-like Cells

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor with poor patient survival that is at least partly caused by malignant and therapy-resistant glioma stem-like cells (GSLCs) that are protected in GSLC niches. Previously, we have shown that the chemo-attractant stromal-derived factor-1α (SDF-1α), its C-X-C receptor type 4 (CXCR4) and the cysteine protease cathepsin K (CatK) are localized in GSLC niches in glioblastoma. Here, we investigated whether SDF-1α is a niche factor that through its interactions with CXCR4 and/or its second receptor CXCR7 on GSLCs facilitates their homing to niches. Furthermore, we aimed to prove that SDF-1α cleavage by CatK inactivates SDF-1α and inhibits the invasion of GSLCs. We performed mass spectrometric analysis of cleavage products of SDF-1α after proteolysis by CatK. We demonstrated that CatK cleaves SDF-1α at 3 sites in the N-terminus, which is the region of SDF-1α that binds to its receptors. Confocal imaging of human GBM tissue sections confirmed co-localization of SDF-1α and CatK in GSLC niches. In accordance, 2D and 3D invasion experiments using CXCR4/CXCR7-expressing GSLCs and GBM cells showed that SDF-1α had chemotactic activity whereas CatK cleavage products of SDF-1α did not. Besides, CXCR4 inhibitor plerixafor inhibited invasion of CXCR4/CXCR7-expressing GSLCs. In conclusion, CatK can cleave and inactivate SDF-1α. This implies that CatK activity facilitates migration of GSLCs out of niches. We propose that activation of CatK may be a promising strategy to prevent homing of GSLCs in niches and thus render these cells sensitive to chemotherapy and radiation.

Citing Articles

A novel classifier combining G protein-coupled receptors and the tumor microenvironment is associated with survival status in glioblastoma.

Guo C, Yu C, Gao W, Ren D, Zhang Y, Zheng P Front Pharmacol. 2023; 14:1093263.

PMID: 37560473 PMC: 10407249. DOI: 10.3389/fphar.2023.1093263.


New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions.

Zhang C, Sheng Y, Sun X, Wang Y Cancer Metastasis Rev. 2023; 42(3):891-925.

PMID: 37368179 PMC: 10584725. DOI: 10.1007/s10555-023-10113-2.


Cathepsins Trigger Cell Death and Regulate Radioresistance in Glioblastoma.

Ding X, Zhang C, Chen H, Ren M, Liu X Cells. 2022; 11(24).

PMID: 36552871 PMC: 9777369. DOI: 10.3390/cells11244108.


Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives.

Mijanovic O, Jakovleva A, Brankovic A, Zdravkova K, Pualic M, Belozerskaya T Int J Mol Sci. 2022; 23(22).

PMID: 36430239 PMC: 9698382. DOI: 10.3390/ijms232213762.


To Explore the Stem Cells Homing to GBM: The Rise to the Occasion.

Tsibulnikov S, Drefs N, Timashev P, Ulasov I Biomedicines. 2022; 10(5).

PMID: 35625723 PMC: 9138893. DOI: 10.3390/biomedicines10050986.